Mitchell Capital Management CO Novartis Ag Transaction History

Mitchell Capital Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$79.7 - $88.13 $245,635 - $271,616	-3,082 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$81.78 - $95.14 $654 - $761	-8 Reduced 0.26%	3,082 $252,000
Q2 2021 Aug 10, 2021	BUY	$85.24 - $94.15 $24,122 - $26,644	283 Added 10.08%	3,090 $282,000
Q1 2021 Apr 29, 2021	BUY	$83.5 - $98.47 $23,463 - $27,670	281 Added 11.12%	2,807 $240,000
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $12,491 - $15,108	160 Added 6.76%	2,526 $239,000
Q3 2020 Nov 10, 2020	BUY	$82.14 - $91.0 $5,996 - $6,643	73 Added 3.18%	2,366 $206,000
Q2 2020 Jul 29, 2020	BUY	$80.93 - $91.1 $185,572 - $208,892	2,293 New	2,293 $200,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Mitchell Capital Management CO, based on Form 13F filings with the SEC.

Stay updated on Mitchell Capital Management CO with notifications on news.